<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170305032893N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-02</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of electroacupuncture in Parkinson's disease</public_title>
      <acronym>-</acronym>
      <scientific_title>Assess the efficacy of Electroacupuncture vs. Sham Acupuncture on Gait in patients with Parkinson's Disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68472</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: The study is conducted in two intervention and sham acupuncture groups. The intervention group receives real acupuncture and the sham acupuncture group does not receive real acupuncture, and special STREITBERGER   needles (needles designed for acupuncture control group) are used. It is exactly the same as real acupuncture without inserting needles into the body, Randomization description: Using Randomaizer.com
Except for the acupuncturist, everyone, including patients and health personnel, outcome assessors and data analysts, are all blind. First, the random numbers site is asked to divide and present 60 random numbers into two groups, A and B. Group A is the electroacupuncture intervention group and group B is the sham echopuncture group, and only the acupuncture interventional physician is aware of this division. The participants in the study  after the referral from the neurologist and the initial assessment and filling out the forms are referred to the acupuncturist to perform the intervention or the sham according according to the assigned number and related group, Blinding description: Participants who do not know the type of intervention and do not know which group they are in.
The outcome evaluator also has no knowledge of the type of intervention.
The data analyst also only has access to the data and does not know about the groups and the intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>PARKINSON.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Acupuncturist will perform acupuncture at predetermined and identical points for all participants in this group. And then the electrodes of the electroacupuncture device are connected to the needles for 20 minutes with an intensity of 1-3 mA and a frequency of 2-100 Hz. It is done twice a week for 4 weeks. Intervention 2: Control group: Special Streitberger needles are used, which gives the patient exactly the sensation of  true acupuncture, but the needle does not penetrate the skin. And it is performed by an acupuncturist in the non-acupuncture points . Also, similar to the intervention group, the electrodes of the electroacupuncture device are connected to the needles, but no current is established.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study specific information

When:
After completing the study and publish the result

To whom:
Project supervisors and persons who have permission from the University Research Council

Conditions:
Only monitoring and not personal and research exploitation

Where to obtain:
Academic council of the university

How to obtain:
Obtaining the opinion of the research council of the university and obtaining the favorable opinion of the researcher

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Babak Asadzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Iranian and Complementary Medicine. Second Floor. Faculty of Medicine. East Gate of Ferdowsi University. Mashhad. Khorasan Razavi</address>
        <city>mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177899191</zip>
        <telephone>+98 51 3855 2189</telephone>
        <email>asadzadehb991@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Khorsand vkilzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Iranian and Complementary Medicine. Second Floor. Faculty of Medicine. East Gate of Ferdowsi University. Mashhad. Khorasan Razavi</address>
        <city>mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177899191</zip>
        <telephone>+98 51 3855 2189</telephone>
        <email>khorsanda@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men/Women with parkinson diagnosis- walk for at least 10 meters without help-disease stable condition and no need to change dosage for two months-able to fillout consent form- no history of tratment of acupuncture
fixed classic medicine regime treatment-parkinson with movment disorder- Hohen$Yar scale 1 to4</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Gait disorder other than parkinson
Life-threatening conditions, mental disorder, alcohol /drug abuse
Electrical device/skin diseases interfere with electroacupuncture
Change of drug dose /type for any reason during the study period
Belonephobia
Coagulation disorder and anticoagulant use
Failure to cooperate in intervention for more than two sessions
Pregnancy
Patients with cardiac arrhythmia
History of dementia or stroke
History of cognitive disorders
History of postural hypotension
Neurological diseases such as Huntington's disease/MS, ALS
History of epilepsy
Acupuncture intolerance
Having DBS(deep brain stimulation)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Parkinson's disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Acupuncturist will perform acupuncture at predetermined and identical points for all participants in this group. And then the electrodes of the electroacupuncture device are connected to the needles for 20 minutes with an intensity of 1-3 mA and a frequency of 2-100 Hz. It is done twice a week for 4 weeks.</i_keyword>
      <i_keyword>Control group: Special Streitberger needles are used, which gives the patient exactly the sensation of  true acupuncture, but the needle does not penetrate the skin. And it is performed by an acupuncturist in the non-acupuncture points . Also, similar to the intervention group, the electrodes of the electroacupuncture device are connected to the needles, but no current is established.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary outcome includes the measurement of gait parameters :single support time , double support time , swing time , velocity , cadence ,stride length , stride time. Timepoint: Start of study, fourth week,twelfth week. Method of measurement: Video recording of walking and data analysis.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sleep problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.</sec_outcome>
      <sec_outcome>Constipation problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.</sec_outcome>
      <sec_outcome>Fatigue based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-06</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Razavi Khorasan Province, Mashhad, Daneshgah Ave mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
